SCHEMBL7182029

SCHEMBL7182029

CCCCCP(CC(C)C)CC(C)C

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.36
TSHR P16473 2/20 0.35
THRB P10828 1/20 0.35
OPRM1 P35372 1/20 0.35
TRPM8 Q7Z2W7 6/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428799 0.97 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529897 0.97 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL2296955 0.97 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529780 0.97 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529870 0.95 DNM1 (0.36) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529735 0.92 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529774 0.92 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529830 0.92 DNM1 (0.40) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL17529782 0.92 DNM1 (0.32) DNM1TSHRTHRBOPRM1TRPM8
SCHEMBL25192948 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2990113-B1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-24 US disclosed
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts MARUZEN PETROCHEMICAL CO., LTD. (JP) 2018-07-03 US disclosed
CN-105163853-B The manufacturing method of cyclic carbonate catalyst for synthesizing 丸善石油化学株式会社 2018-06-12 CN disclosed
US-9834536-B2 Method for producing catalyst for cyclic carbonate synthesis NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-12-05 US disclosed
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-04-21 US disclosed
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS MARUZEN PETROCHEMICAL CO., LTD. (JP) 2016-03-10 US disclosed
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-03-03 US disclosed
EP-2990114-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS National Institute of Advanced Industrial Science and Technology (JP) 2016-03-02 EP disclosed
EP-2990113-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
EP-2990112-A1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE Maruzen Petrochemical Co., Ltd. (JP) 2016-03-02 EP disclosed
CN-1216889-C Bidentate ligands useful in catalyst system SHELL INT RESEARCH (NL) 2005-08-31 CN disclosed
CN-1429228-A Bidentate ligands useful in catalyst system SHELL INT RESEARCH (NL) 2003-07-09 CN disclosed
EP-1282629-A1 BIDENTATE LIGANDS USEFUL IN CATALYST SYTEMS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2003-02-12 EP disclosed
WO-2001087899-A1 BIDENTATE LIGANDS USEFUL IN CATALYST SYSTEM SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067695-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CYCS, CA7, CA9 DNM1 1282/4885TSHR 4511/4885THRB 4718/4885
US-10029241-B2 Method for producing catalyst for cyclic carbonate synthesis CYCS, CA7, CA9 DNM1 1282/4885TSHR 4511/4885THRB 4718/4885
US-20160108071-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS EPHX2, CA4, CA9 DNM1 3936/4885TSHR 4242/4885THRB 4806/4885
US-20160060242-A1 METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS CA2, PLCB3, PHOSPHO1 DNM1 1901/4885TSHR 3716/4885THRB 4710/4885
US-10011621-B2 Method for producing silica gel-immobolized phosphonium salt catalysts SIK2, SIK3, SIK1 DNM1 4452/4885TSHR 3660/4885THRB 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.